Diabetes, Obesity and Metabolism

Diabetes, Obesity and Metabolism
Publié: (2024)

Diabetes, Obesity and Metabolism
Publié: (2024)

Diabetes, Obesity and Metabolism
Publié: (2024)

Diabetes, Obesity and Metabolism
Publié: (2024)

Diabetes, Obesity and Metabolism
Publié: (2026)

Diabetes, Obesity and Metabolism
Publié: (2025)

Diabetes, Obesity and Metabolism
Publié: (2025)

Diabetes, Obesity and Metabolism
Publié: (2026)

Diabetes, Obesity and Metabolism
Publié: (2025)

Diabetes, Obesity and Metabolism
Publié: (2025)

Diabetes, Obesity and Metabolism
Publié: (2026)

Diabetes, Obesity and Metabolism
Publié: (2025)

Diabetes, Obesity and Metabolism
Publié: (2025)

Diabetes, Obesity and Metabolism
Publié: (2025)

Diabetes, Obesity and Metabolism
Publié: (2025)

The Duodenal Mucosa Plays a Key Role in Metabolic Regulation: Emerging Physiology and New Opportunities for Cell‐Directed and Barrier‐Related Interventions for the Treatment of Diabetes and Obesity
par: David A. D’Alessio, et autres
Publié: (2026)

Association of Physical Activity With All‐Cause and CVD Mortality Across Metabolic and Obesity Phenotypes
par: Yunmin Han, et autres
Publié: (2026)

Real‐World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non‐Diabetic Adults
par: Mai Katsura, et autres
Publié: (2026)

Coexisting Asthma and Diabetes Are Associated With Adverse Metabolic and Inflammatory Profiles
par: Sixtus Aguree, et autres
Publié: (2026)

Obesity and Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ): A Literature Review on Pathophysiology and Treatment
par: Michael Romanos, et autres
Publié: (2026)

Waist‐to‐Height Ratio and the Risk of Cardiovascular Outcomes and Mortality in Type 2 Diabetes With and Without Abdominal Obesity
par: Kye‐Yeung Park, et autres
Publié: (2026)

The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress
par: Renata Risi, et autres
Publié: (2026)

Enriched Metabolic Phenotyping Refines Phenotypic Resolution of Type 2 Diabetes
par: Min Wang, et autres
Publié: (2026)

REduced‐Carbohydrate intervention for managing Obesity and Reduction of gestational Diabetes ( RECORD ): A randomized controlled feasibility trial
par: Moscho Michalopoulou, et autres
Publié: (2024)

Associations of Visceral Obesity Indices and Risk of Mild Cognitive Impairment in Patients With Diabetes: A Retrospective Cohort Study
par: Jingyi Jiao, et autres
Publié: (2026)

Beyond GLP ‐1 Monotherapy: Novel Multi‐Agonists, Amylin Analogues, and Combination Strategies in Obesity and Type 2 Diabetes
par: Mikhail Khachaturov, et autres
Publié: (2026)

Prevalence of Cardiovascular‐Kidney‐Metabolic Conditions Across Body Mass Index Categories: The Distinct Burden of Severe (Class III ) Obesity
par: Saif S. Rathore, et autres
Publié: (2026)

Efficacy and Safety of Mazdutide in Managing Overweight and Obesity Among Non‐Diabetic Adults: A Meta‐Analysis of Randomised Controlled Trials
par: Muhammad Hassan Azam, et autres
Publié: (2026)

Exercise Metabolic Flexibility in Type 2 Diabetes Treated With Empagliflozin: An Exploratory Analysis of the Randomised Trial EMPA ‐ HEART
par: Lorenzo Nesti, et autres
Publié: (2026)

Meta‐analysis of randomized controlled trials for the development of the International Federation for Surgery of Obesity and Metabolic Disorders‐European Chapter (IFSO‐EC) guidelines on multimodal strategies for the surgical treatment of obesity
par: Maurizio De Luca, et autres
Publié: (2025)

Adherence to the EAT ‐Lancet Diet, Genetic Susceptibility and Risk of Obesity and Obesity‐Related Morbidities: A Prospective Cohort Study
par: Huan‐Cong Zheng, et autres
Publié: (2026)

Real‐World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido‐ TZP Study
par: Fumika Maruyama, et autres
Publié: (2026)

Serum Short‐Chain Fatty Acid Profiles as Metabolic Signatures of Diabetic Cognitive Impairment: Multinomial Modelling and Internally Validated Multiclass Discrimination
par: Jie Zheng, et autres
Publié: (2026)

Obesity mortality on the rise: A 54‐year US perspective
par: Jazza Aamir, et autres
Publié: (2025)

Obesity in Late Adolescence and Healthcare Costs in Young to Mid‐Adulthood
par: Cheli Melzer Cohen, et autres
Publié: (2026)

Efficacy, Safety and PK of Once‐Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model‐Informed Drug Development Approach
par: Rune Viig Overgaard, et autres
Publié: (2026)